INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 194 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,808,000 | +80.6% | 54,942 | -3.3% | 0.53% | +138.9% |
| Q3 2019 | $3,769,000 | -16.6% | 56,794 | 0.0% | 0.22% | +10.0% |
| Q2 2019 | $4,519,000 | -31.0% | 56,794 | -12.6% | 0.20% | -9.5% |
| Q4 2018 | $6,547,000 | -20.2% | 64,961 | 0.0% | 0.22% | +40.5% |
| Q3 2018 | $8,208,000 | +50.6% | 64,961 | 0.0% | 0.16% | +66.3% |
| Q2 2018 | $5,451,000 | +36.4% | 64,961 | 0.0% | 0.10% | +18.8% |
| Q1 2018 | $3,996,000 | – | 64,961 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |